Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
JOHNSON & JOHNSON
   2. Issuer Name and Ticker or Trading Symbol
Aldeyra Therapeutics, Inc. [ALDX] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last)
(First)
(Middle)
ONE JOHNSON & JOHNSON PLAZA		 3. Date of Earliest Transaction (Month/Day/Year)
05/01/2014
(Street)

NEW BRUNSWICK, NJ 08933		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Filing(Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 05/01/2014   C   1,724,478 A $ 0 (2) 1,724,478 I Johnson & Johnson Development Corporation (1)
Common Stock 05/01/2014   M   36,345 A $ 5.16 1,760,823 I Johnson & Johnson Development Corporation (1)
Common Stock 05/01/2014   F   23,438 D $ 8 1,737,385 I Johnson & Johnson Development Corporation (1)
Common Stock 05/01/2014   M   36,345 A $ 5.16 1,773,730 I Johnson & Johnson Development Corporation (1)
Common Stock 05/01/2014   F   23,438 D $ 8 1,750,292 I Johnson & Johnson Development Corporation (1)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Series A Preferred Stock (2) 05/01/2014   C     385,800   (2)   (2) Common Stock 915,366 $ 0 0 I By Johnson & Johnson Development Corporation (1)
Non-Voting Series A Preferred Stock (2) 05/01/2014   C     104,396   (2)   (2) Common Stock 247,694 $ 0 0 I By Johnson & Johnson Development Corporation (1)
Series B Preferred Stock (2) 05/01/2014   C     427,591   (2)   (2) Common Stock 427,591 $ 0 0 I By Johnson & Johnson Development Corporation (1)
Non-Voting Series B Preferred Stock (2) 05/01/2014   C     133,827   (2)   (2) Common Stock 133,827 $ 0 0 I By Johnson & Johnson Development Corporation (1)
Series B Preferred Stock Warrant (Right to Buy) $ 5.16 05/01/2014   M     36,345   (2)(3) 12/20/2017 Common Stock (2) (3) 36,345 $ 0 0 I By Johnson & Johnson Development Corporation (1)
Series B Preferred Stock Warrant (Right to Buy) $ 5.16 05/01/2014   M     36,345   (2)(3) 08/14/2018 Common Stock (2) (3) 36,345 $ 0 0 I By Johnson & Johnson Development Corporation (1)

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
JOHNSON & JOHNSON
ONE JOHNSON & JOHNSON PLAZA
NEW BRUNSWICK, NJ 08933		     X    
JOHNSON & JOHNSON DEVELOPMENT CORP ET AL
ONE JOHNSON & JOHNSON PLAZA
NEW BRUNSWICK, NJ 08933		     X    

Signatures

 Douglas Chia, Secretary of Johnson & Johnson   05/02/2014
**Signature of Reporting Person Date
 Steven M. Rosenberg, Secretary of Johnson & Johnson Development Corporation   05/02/2014
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person.
(2) All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock immediately following declaration of effectiveness of the Issuer's Registration Statement for no additional consideration. Each share of Series A Preferred Stock and Non-Voting Series A Preferred Stock converted into shares of Common Stock on a 2.3726-for-1 basis and each share of Series B Preferred Stock and Non-Voting Series B Preferred Stock automatically converted into shares of Common Stock on a 1-for-1 basis.
(3) All outstanding warrants were net exercised for shares of the Issuer's Series B Preferred Stock and subsequently automatically converted into Common Stock following declaration of effectiveness of the Issuer's Registration Statement for no additional consideration. Each share of Series B Preferred Stock automatically converted into shares of Common Stock on a 1-for-1 basis.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.